iCliniq Logo
HomeHealth articlesPediatricsleukemia

Juvenile Myelomonocytic Leukemia - An Overview

Verified data
0

5 min read

Share

Outline

Children with juvenile myelomonocytic leukemia, usually those four years of age and younger, are affected by this uncommon kind of chronic leukemia.

Medically reviewed byDr. Rakesh Radheshyam Gupta

Published At August 29, 2024
Reviewed AtAugust 29, 2024

What Is Leukemia?

White blood cells are primarily affected by leukemia, a kind of malignancy. Leukocytes, another name for white blood cells, are immune system combatants. White blood cells, red blood cells, and platelets are produced in the spongy bone marrow found inside the bones. The bone marrow produces white blood cells in leukemia, but they are ineffective. The body cannot be protected against infections by these aberrant cells. They can infect the liver, brain, lymph nodes, and other areas of the body once they overcrowd the bone marrow and reach the bloodstream. Children most commonly suffer from leukemia. It may grow slowly or rapidly in an urgent situation. With treatment, leukemia is cured in the majority of children and teenagers.

What Is Juvenile Myelomonocytic Leukemia?

A condition known as juvenile myelomonocytic leukemia (JMML) results from the overproduction of myelocytes and monocytes, two types of white blood cells, by immature blood cells known as blasts. Problems arise when normal cells in the bone marrow and other body organs are overcrowded by myelocytes, monocytes, and blasts.

It is a rare blood cancer that shares characteristics with two other blood cancer kinds. Juvenile myelomonocytic leukemia (JMML) is categorized as a “myelodysplastic/ myeloproliferative neoplasm” by the World Health Organisation (WHO). JMML typically affects children under the age of four and is mostly seen in males. Numerous children have a genetic alteration (mutation) that impacts the monocytes. It represents between one and two percent of all instances of childhood leukemia. Children who have certain medical disorders (such as neurofibromatosis type 1 and Noonan syndrome) are more susceptible to the disease.

What Are the Other Names of Juvenile Myelomonocytic Leukemia?

  • Juvenile chronic myeloid leukemia (JCML).

  • Chronic and subacute myelomonocytic leukemia.

  • Infantile monosomy 7 syndrome.

  • CMML of childhood.

What Are the Symptoms of Juvenile Myelomonocytic Leukemia?

JMML takes weeks or months to develop fully. Children may exhibit very few symptoms at first. They may eventually experience anemia, a condition in which the body produces insufficient red blood cells. This results from the bone marrow's cessation of normal red blood cell production.

  • Anemia: Anemia is the result of an excess of leukemia cells in the bone marrow, which prevents the production of healthy red blood cells. The youngster who is anemic may appear pale, require more naps, be more exhausted, and have a beating heart. A blood count's "hemoglobin" or "hematocrit" value will be lower than usual.

  • Bruising and Bleeding: When the bone marrow is unable to generate enough platelets, bleeding may happen, particularly if the platelet count is below 10–20,000/mm3. A youngster who has low platelets may bruise or bleed more easily.

  • Pain in the Bones and Joints: Leukemic blasts packed into the bone marrow are typically the cause of pain in the bones and joints. This is frequently misinterpreted as "growing pains."

  • Recurrent Fevers and Infections: Fever and exhaustion are common non-specific signs of infection in children with leukemia. A child with leukemia may have a high white blood cell count, but these cells are immature and do not typically fight infection. Consequently, the child may experience challenges recuperating from a common childhood ailment or may get uncommon infections.

  • Pain in the Abdomen: Leukemia cells can accumulate in the spleen, liver, and kidneys, causing these organs to expand and produce abdominal pain. Loss of appetite and weight loss may result from this pain.

  • Swollen Lymph Nodes: Blood is filtered by lymph nodes. Nodes frequently become swollen due to the accumulation of leukemia cells. Nodes in the neck, groin, underarms, and chest all experience swelling. Differentiating leukemia lymph nodes from those that are a typical reaction to an illness or allergy might be challenging at times.

  • Breathing Difficulties: Leukemia patients may have clumps of cells in the thymus gland, which is located under the breastbone and surrounds the throat. Breathing may be difficult because of this clump of cells. Any coughing, wheezing, or difficult or painful breathing needs to be treated medically very away.

Children with leukemia are more susceptible to bacterial or viral infections because their white blood cells are unable to fight off infections. Leukemia can occasionally metastasize, or spread. If it travels to the brain, headaches, seizures, issues with balance or vision issues could be experienced. Breathing issues and chest pain are possible symptoms if it spreads to the lymph nodes in the chest.

How Is Juvenile Myelomonocytic Leukemia Diagnosed?

  • Blood Testing: Examinations such as a full blood count, panels for liver and kidney function, and blood chemistry tests can provide crucial details regarding the quantity of healthy red blood cells in the body and the efficiency of the organs. A microscope is used to examine the sizes and forms of the blood cells.

  • Imaging Studies: These could be an ultrasound, CT scan, MRI, or X-ray. These help doctors look for a mass of leukemia cells in the chest that could impair breathing or blood circulation, or they help rule out other possible explanations of the symptoms.

  • Spinal Tap: Spinal tap is also known as lumber puncture. The physician extracts a tiny volume of cerebrospinal fluid (the fluid that surrounds the brain and spinal cord) using a hollow needle. Cancerous cells are examined in the fluid. This facilitates treatment planning for medical professionals.

  • Bone Marrow Aspiration and Biopsy: A child is given medication to help them sleep and feel comfortable during this treatment. The surgeon next extracts a tiny quantity of bone marrow by inserting a needle into a big bone, typically the hip. These tests are performed in a lab on the bone marrow sample:

    • Flow Cytometry Tests: Pathologists identify the leukemia type and subtype by closely examining the cancer cells. This information is significant because different forms of leukemia require different treatments.

    • Tissue Typing: Tissue typing, also known as HLA (human leukocyte antigen) typing, is a procedure that aids in the identification of a potential stem cell donor for a kid in need of a bone marrow or stem cell transplant. It does this by comparing the proteins on the child's blood cells' surface to those on the cells of a possible donor. The likelihood of a successful transplant increases with the number of HLA markers that the recipient and recipient share.

    • Genetic Tests: Physicians examine blood or bone marrow to look for alterations in the genetic code. This can assist them in determining the optimal course of action.

What Is the Treatment for Juvenile Myelomonocytic Leukemia?

Chemotherapy, which involves using medications to kill cancer cells, may be used initially to control JMML. However, a bone marrow stem cell transplant is the most successful course of treatment. To carry out this, physicians:

  • To kill cancer cells as well as healthy bone marrow and immune system cells, use high-dose chemotherapy.

  • Infuse the body with healthy donor stem cells. An immunological system and a healthy blood supply can be restored by the new stem cells.

Other treatments being investigated by researchers include:

  • Molecularly Targeted Therapies: These medications inhibit specific chemicals or proteins that support the proliferation of cancer cells, thereby slowing the spread of cancer cells.

  • Immunotherapy: These medications identify cancer cells so that the body's defenses can eliminate them.

What Is the Prognosis of Juvenile Myelomonocytic Leukemia?

The prognosis of juvenile myelomonocytic leukemia (JMML), a kind of leukemia that affects children, can vary widely. Even with medication, more than 90 percent of JMML patients died before hematopoietic stem cell transplantation (HSCTs). Nonetheless, survival rates have increased by about 50 percent, thanks to HSCTs. After a transplant, there is a 50 percent chance of relapse, and if JMML returns, a second transplant might be necessary.

Conclusion:

Young children who have juvenile myelomonocytic leukemia (JMML) are victims of this uncommon blood malignancy. One type of cancer that mostly affects white blood cells is leukemia. White blood cells, often known as leukocytes, are immune system fighters. Within the bones is a spongy bone marrow that produces red blood cells, white blood cells, and platelets. The bone marrow produces white blood cells in leukemia; however, they are useless. These abnormal cells cannot defend the body from illnesses. Once they overcrowd the bone marrow and enter the bloodstream, they can infect the liver, brain, lymph nodes, and other parts of the body. In a crisis, it could expand quickly or slowly. Most children and teens with leukemia recover with treatment.

Listen to related tracks in our music library
Source Article IclonSourcesSource Article Arrow

Tags:

leukemia

Ask your health query to a doctor online

Pediatrics

*guaranteed answer within 4 hours

Disclaimer: No content published on this website is intended to be a substitute for professional medical diagnosis, advice or treatment by a trained physician. Seek advice from your physician or other qualified healthcare providers with questions you may have regarding your symptoms and medical condition for a complete medical diagnosis. Do not delay or disregard seeking professional medical advice because of something you have read on this website. Read our Editorial Process to know how we create content for health articles and queries.